AA
EUCRW

Ancora Advisors’s Eucrates Biomedical Acquisition Corp. Warrant EUCRW Stock Holding History

Ancora Advisors’s Portfolio EUCRW Stock Details EUCRW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-47
Closed – – 2145
2022
Q4 		$0 Hold
47
– – ﹤0.01% 2173
2022
Q3 		$0 Hold
47
– – ﹤0.01% 2318
2022
Q2 		$0 Hold
47
– – ﹤0.01% 2463
2022
Q1 		$0 Buy
+47
New – ﹤0.01% 2662